Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Ovarian Neoplasms

  Free Subscription


22.07.2019

1 Anticancer Drugs
1 BMC Cancer
1 Cancer Res
1 Eur J Obstet Gynecol Reprod Biol
1 Gynecol Oncol
1 Int J Oncol
1 Oncol Rep


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Anticancer Drugs

  1. VILLA M, Attianese D, Petracchini M, Ferrero A, et al
    Oral metronomic cyclophosphamide in advanced ovarian cancer: long-lasting clinical response in an elderly frailty patient.
    Anticancer Drugs. 2019 Jul 11. doi: 10.1097/CAD.0000000000000815.
    PubMed     Text format     Abstract available


    BMC Cancer

  2. GONG W, Liu Y, Seidl C, Diamandis EP, et al
    Quantitative assessment and clinical relevance of kallikrein-related peptidase 5 mRNA expression in advanced high-grade serous ovarian cancer.
    BMC Cancer. 2019;19:696.
    PubMed     Text format     Abstract available


    Cancer Res

  3. FUKUMOTO T, Fatkhutdinov N, Zundell JA, Tcyganov EN, et al
    HDAC6 inhibition synergizes with anti-PD-L1 therapy in ARID1A-inactivated ovarian cancer.
    Cancer Res. 2019 Jul 16. pii: 0008-5472.CAN-19-1302.
    PubMed     Text format     Abstract available


    Eur J Obstet Gynecol Reprod Biol

  4. TOZZI R, Casarin J, Baysal A, Pinelli C, et al
    Morbidity of multiple bowel resection compared to single bowel resection after debulking surgery for ovarian cancer.
    Eur J Obstet Gynecol Reprod Biol. 2019;240:215-219.
    PubMed     Text format     Abstract available


    Gynecol Oncol

  5. XIANG L, Ye S, Yang H
    Total pelvic peritonectomy for ovarian cancer with extensive peritoneal carcinomatosis in pelvic cavity.
    Gynecol Oncol. 2019 Jul 17. pii: S0090-8258(19)31352.
    PubMed     Text format     Abstract available


    Int J Oncol

  6. SEKIYA A, Suzuki S, Tanaka A, Hattori S, et al
    Interleukin33 expression in ovarian cancer and its possible suppression of peritoneal carcinomatosis.
    Int J Oncol. 2019 Jul 17. doi: 10.3892/ijo.2019.4845.
    PubMed     Text format     Abstract available


    Oncol Rep

  7. LUO H, Wang X, Ge H, Zheng N, et al
    Inhibition of ubiquitinspecific protease 14 promotes connexin 32 internalization and counteracts cisplatin cytotoxicity in human ovarian cancer cells.
    Oncol Rep. 2019 Jul 15. doi: 10.3892/or.2019.7232.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: